Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy

Diabetes Research and Clinical Practice

Volumn 65, Issue 3, 2004, Pages 257-265

  Shin Shin, Young ^a   Baek, Sang Hong ^a   Chang, Ki Yuk ^a   Park, Cheol Whee ^a   Yang, Chul Woo ^a   Jin, Dong Chan ^a   Kim, Yong Soo ^a   Chang, Yoon Sik ^a   Bang, Byung Kee ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

ACE gene; eNOS gene; Polymorphism; Type 2 diabetic nephropathy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURVIVAL;

COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIPEPTIDES; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 4344619822     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.01.010     Document Type: Article

References (19)

1. UKPDS: intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), UK Prospective Diabetes Study (UKPDS) Group, Lancet 12 (1998) 837-853.
2. A. Mogyorosi, F.N. Ziyadeh, Selected topics in diabetic nephropathy, in: S.G. Massary, R.J. Glassock (Eds.), Massary and Glassock's Textbook of Nephrology, Lippincott Williams and Wilkins, Philadelphia, 2001, p. 885.
3. Ismail N., Becker B., Strzelczyk P., Ritz E. Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int. 55:1999;1-28
4. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:1993;2002-2012
5. Schmidt H.W., Walter U. NO at work. Cell. 78:1994;919-925
6. Hallab M., Bled F., Ebran J.M., et al. Elevated serum angiotensin I converting enzyme activity in type I insulin-dependent diabetic subjects with persistent macroalbuminuria. Acta Diabetol. 29:1992;82-83
7. Nakamoto H., Ferrario C.M., Fuller S.B., Robaczewski D.L., Winicov E., Dean R.H. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension. 25:1995;796-802
8. Patzak A., Mrowka R., Stroch E., Hocher B., Persson P.B. Interaction of angiotensin II and nitric oxide in isolated perfused afferent arterioles of mice. J. Am. Soc. Nephrol. 12:2001;1122-1127
9. The Expert Committee on the diagnosis and classification of diabetes mellitus, Report of the Expert Committee on the diagnosis and classification of diabetes mellitus, Diabetes Care 21 (Suppl. 1) (1998) S5-S22.
10. America Diabetes Association, Diabetic nephropathy, Diabetes Care 21 (Suppl. 1) (1998) S50-S53.
11. Lacolley P., Gautier S., Poirier O., Pannier B., Cambien F., Benetos A. Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J. Hypertension. 16:1998;31-35
12. Zanchi A., Moczulski D.K., Hanna L.S., Wantman M., Warram J.H., Krolewski A.S. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 57:2000;405-413
13. Neugebauer S., Baba T., Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes. 49:2000;500-503
14. Noiri E., Satoh H., Taguchi J., et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension. 40:2002;535-540
15. Sugimoto H., Shikata K., Matsuda M., et al. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia. 41:1998;1426-1434
16. Tsukada T., Yokoyama K., Arai T., et al. Evidence of associatiobn of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 245:1998;190-193
17. Dudly C.R.K., Keavney B., Stratton I.M., Turner R.C., Ratcliffe P.J. U.K. Prospective Diabetes Study XV: relationship of renin-angiotensin system gene polymorphism is associated with microalbuminuria in NIDDM. Kidney Int. 48:1995;1907-1911
18. The Diabetes Control and Complications Trial Research Group, Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial, Kidney Int. 47 (1995) 1703-1720.
19. Vibert G.C. on behalf on the Microalbuminuria Collaborative Study Group Intensive therapy fails to prevent overt nephropathy in insulin-dependent diabetics with microalbumiuria [abstract]. Diabetologia. 37(Suppl. 1):1994;A19